Skip to main content
OpenTrials

Clinical trial condition

Hematologic Malignancy

Explore clinical trials studying Hematologic Malignancy. Study availability and eligibility vary by location and protocol.

166 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Malignancy trial results

Active, not recruiting

CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT

NCT06449586

Conditions
Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +3 more
Locations
  • Tongji Hospital of Huazhong University of Science and Technology, Wuhan Wuhan, Hubei, China
  • Ruijin Hospital of Shanghai Jiaotong University Shanghai, Shanghai Municipality, China
  • The First Hospital of Zhejiang University School of Medicine Hangzhou, Zhejiang, China
  • Ruijin Hospital, Shanghai JiaoTong University School of Medicine Shanghai, China
View Trial Details
Active, not recruiting

Critical Care Outcomes of Hematologic Oncology Patients

NCT03449953

Conditions
Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +4 more
Locations
  • Foothills Hospital Calgary, Alberta, Canada
  • University of Alberta Edmonton, Alberta, Canada
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • University of Manitoba Winnipeg, Manitoba, Canada
View all 13 locations
View Trial Details
Completed

Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens

NCT01572181

Conditions
Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +3 more
Locations
  • University Hospital Besançon, France
  • University Hospital Bordeaux, France
  • University Hospital Clermont-Ferrand, France
  • University Hospital Grenoble, France
View all 15 locations
View Trial Details

Related conditions